-
August 7, 2020
FDA Approves Merck’s Keytruda, Foundation Medicine CDx for TMB-High Solid TumorsBookmark
George Lundberg, MDArticle from GenomeWeb curated by Editor in Chief George Lundberg, MD, who notes:
The U.S. Food and Drug Administration (FDA) has approved the drug pembrolizumab (brand name Keytruda) for solid tumors based solely on whether they have a high tumor mutational burden—a high number of changes in the DNA of the cancer cells.
Go to full article published by GenomeWeb.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 2, 2019
Pembrolizumab Plus Lenvatinib Approved for Endometrial CancerBookmark
George Lundberg, MDArticle from Cancer Network curated by Editor in Chief George Lundberg, MD, who notes:
The U.S. Food and Drug Administration (FDA) has approved a new combination therapy for certain advanced endometrial cancers.
Go to full article published by Cancer Network.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 17, 2019
Endometrial Carcinoma—An OverviewBookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
There are two principal forms of uterine cancer: cervical and endometrial. Endometrial carcinoma is the most frequent cancer of the female genitalia in the developed world, with about 3% of U.S. women likely to receive such a diagnosis. This 2018 review from Medscape is comprehensive. -
January 12, 2019
Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical CancerBookmark
George Lundberg, MDResearch paper from the Journal of the National Comprehensive Care Network curated by Editor in Chief George Lundberg, MD, who notes:
Metastatic or advanced cervical cancer remains very difficult to treat. Immunotherapy is showing promise.Go to full article published in the Journal of the National Comprehensive Care Network.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
Show More
Keith Flaherty, MD
Cancer Commons Advisor
Latest Clinical Trial Results in Uterine Cancer
Some of the most promising new treatments for metastatic uterine cancer are currently being tested in patients enrolled in clinical trials. We help you stay up to date on the latest results from these studies.
-
August 26, 2019
CAR T-cell Therapy for HPV-Induced Metastatic Cervical CancerBookmark
George Lundberg, MDResearch paper from the Journal of Clinical Oncology, selected by Editor in Chief George Lundberg, MD, who notes:
CAR T-cell therapy has been approved by the U.S. Food and Drug Administration (FDA) for certain hematologic malignancies. This early study demonstrates its effectiveness in human papillomavirus (HPV)-induced metastatic cervical cancer as well.
Go to full article published by the Journal of Clinical Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
Show More
Navigating Treatment
The world of advanced cancer treatment can be complex and confusing. Get oriented with tips on what to ask your doctor, second opinions, how to enroll in a clinical trial, and more.
-
August 18, 2020
Tumor Boards—What Are They and How Can They Help You?
One of the most powerful tools in cancer treatment today is the tumor board—a group of cancer experts who delve into individual cancer patients’ cases to help them explore their… Read more »
-
June 30, 2020
Helping Cancer Patients Access their Own Health Data
With:For many cancer patients, the ability to access one’s own medical records can aid their treatment decisions, or allow them to donate their personal data for research that could help… Read more »
-
December 13, 2019
Cervical Cancer – OverviewBookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
The third leading cause of cancer death of women in developing countries, advanced cervical cancer is relatively rare in the U.S. This comprehensive review summarizes it nicely.
.
-
September 6, 2019
What Questions Should I Ask My Doctor?
Sarah StanleyWhen faced with an advanced cancer diagnosis, it can be difficult to know what questions to ask. At Cancer Commons, we help patients and caregivers navigate a vast sea of… Read more »
-
May 21, 2019
Can You Improve Your Response to Certain Immunotherapy Drugs?
Emma Shtivelman, PhDCancer treatments that use a strategy called immune checkpoint blockade (ICB) have entered clinical practice in a big way, with six drugs now approved by the U.S. Food and Drug… Read more »
-
March 19, 2019
At Diagnosis, What Do Cancer Patients Want?
With:A Q&A with Laura Benson, RN, MS, ANP, president of Conversations in Care, LLC; LauraBensonRN@Gmail.com Q: In our digital communication world of 2019, some patients may receive the initial message that… Read more »
Show More
Marty Tenenbaum, PhD
Founder of Cancer Commons
Living With Cancer
Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.
-
October 14, 2019
Pediatric Palliative Care: A Specialty Comes of Age
For a child with cancer, palliative care can provide much-needed relief from stress and symptoms—for the patient and their family alike. Palliative care is given alongside cancer treatment, and is… Read more »
-
February 11, 2020
‘Impressed With Impact’ of Ketamine in Cancer Palliative CareBookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Depression is, for obvious reasons, common in patients with advanced cancer. The old, inexpensive drug ketamine—already approved for medical use by the U.S. Food and Drug Administration (FDA)—seems rapidly effective, according to small studies.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
October 7, 2019
Emphasizing Oncogeriatrics
With:A Q&A with Nicolò Matteo Luca Battisti, MD, Medical Oncologist at The Royal Marsden NHS Foundation Trust, London, United Kingdom, and Chair of the Young Interest Group of the International… Read more »
-
December 3, 2018
Best Uses of Physical Medicine and Rehabilitation in Patients with Cancer
With:A Q&A with Val Jones, MD, Medical Director of Admissions, Saint Luke’s Rehabilitation Institute, Spokane, WA Originally published February 1, 2017 Q: Your principal practice in Spokane, Washington is physical… Read more »
-
September 14, 2018
Huge Progress in Palliative Care
With:A Q&A with Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care; Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai; New York, NY;… Read more »
-
July 23, 2018
Cancer Pain and the Opioid Epidemic
George Lundberg, MDA Q&A with Kevin Sevarino, MD, PhD, President-elect of the American Academy of Addiction Psychiatry and Consulting Psychiatrist at Gaylord Hospital in Wallingford, CT Q: Opioid abuse, addiction, and overdose… Read more »
Show More
-
Molecular Testing Guides Treatment for Claudius’s Lung Cancer
Sarah Stanley Science Writer at Cancer Commons
-
How to Advocate for Yourself: Advice from an Empowered Lymphoma Patient
Brad Power Lymphoma patient and Founder of Reengineering Cancer Treatment
-
Grace Faces Anal Cancer with Strength, Support, and Song
Sarah Stanley Science Writer at Cancer Commons
-
Pushing for the Best Possible Treatment for My Stage 4 Breast Cancer
Karen Peterson Advanced breast cancer patient
-
Carla Takes Charge of Her Own Lung Cancer Treatment
Carla A Cancer Commons lung cancer patient
The Big Picture
Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.
-
September 9, 2020
Is Cancer the Best Way to Die?
With:In 2014, the prestigious medical research journal The BMJ published a controversial piece called “Dying of cancer is the best death.” Here, our Curious Dr. George asks the author of that… Read more »
-
August 21, 2020
The Power of Precision Medicine is Exemplified by Tempus
With:Tempus—a tech company & partner of Cancer Commons—empowers doctors to make data-driven decisions for their patients in real time. Learn how.
-
June 29, 2020
Cancer Screening Programs Influence Incidence and Causes of Cancer DeathsBookmark
Lola Rahib, PhDArticle from ASCO Daily News curated by Director of Scientific and Clinical Affairs, Lola Rahib, PhD.
In collaboration with MD Anderson Cancer Center and the Pancreatic Cancer Action Network, Cancer Commons presented new research at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. The findings show that, by 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. This research was led by Dr. Rahib at Cancer Commons.
Go to full article published by ASCO Daily News.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 30, 2020
What Have I Learned in More Than Half a Century in Cancer Medicine?Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
“Patients with cancer need to be embraced with love and compassion. They need caring beyond medicine.”Go to full article published by The ASCO Post.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
April 27, 2020
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
With: Razelle Kurzrock, MDJeff Shrager, PhDIn a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile.… Read more »
-
March 2, 2020
Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology
With: Razelle Kurzrock, MDA Q&A with Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and the Rare Tumor Clinic at U.C. San Diego, and Co-Founder and Board Member of CureMatch,… Read more »
Show More
Cancer and Covid-19
The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.
-
June 10, 2020
How I Cope with the Tsunami of Cancer and COVID-19 Info
With: Kevin Knopf, MD, MPHOncologists worldwide face the challenge of staying on top of the latest treatments, research findings, and other information that could help them treat their patients more effectively. Now, they must… Read more »
-
August 7, 2020
Clinical Trials Gone VirtualBookmark
George Lundberg, MDArticle from GenomeWeb curated by Editor in Chief George Lundberg, MD, who notes:
During the COVID-19 pandemic, some clinical trials have gone virtual.
Go to full article published by GenomeWeb.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 20, 2020
How the Coronavirus Pandemic Impacts Cancer Care: Our Survey Results
With: Lola Rahib, PhDThe ongoing COVID-19 pandemic presents unprecedented challenges to cancer patients. Many have experienced changes to their care, and some face increased risk of infection or worse prognosis if they are… Read more »
-
April 14, 2020
What Cancer Patients and Caregivers Need to Know About the Coronavirus Disease
In light of the ongoing coronavirus disease (COVID-19) pandemic, cancer patients may be wondering how their medical situation affects their vulnerability to infection and other ways the pandemic will affect… Read more »
-
April 3, 2020
How to Beat COVID-19 with Real-Time, Real-World Data
With: Mark Shapiro, PhDAs the COVID-19 pandemic continues, researchers around the world are working quickly to develop strategies to treat and prevent this disease. In partnership with the company xCures, Cancer Commons is… Read more »
-
March 17, 2020
These Underlying Conditions Make Coronavirus More Severe, and They’re Surprisingly CommonBookmark
George Lundberg, MDExcerpt from a National Geographic article:
“For now, the sole intervention for vulnerable cancer patients is social distancing and enhanced hygiene practices for their family and health care workers.”
Go to full article published by National Geographic.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
Show More
